MO01.10 Activity of Lurbinectedin in Second-line SCLC Patients Who Are Candidates for Platinum Rechallenge

Autor: Subbiah, V., Paz-Ares, L., Besse, B., Zaman, K., Sala, M.A., López-Vilariño, J.A., Fernández, C., Kahatt, C., Siguero, M., Zeaiter, A., Arrondeau, J., Delord, J.-P., Martínez, M., Antón, A., Trigo, José M., Wannesson, L.
Zdroj: In Journal of Thoracic Oncology January 2021 16(1) Supplement:S19-S20
Databáze: ScienceDirect